Stay updated with breaking news from Scala Biodesign. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The partners will leverage IBM’s foundation model technologies to help identify antibodies designed to target and neutralize various disease-causing agents or cells.
The pharma giant's new health tech company will operate as a separate business and scale the company's already established digital technologies to enhance clinical trials.
Israel High Tech Scene September 9 – September 15 New Startups / VC Funding Israel’s UBQ Materials Raises $70 Million to Make ‘Plastics’ From Recycled Waste UBQ Materials, an Israeli climate tech startup that develops advanced materials from waste, has raised $70 million in funding, led by Eden Global Partners. Additional investors include TPG Rise […]
According to a new report, more than eight out of 10 VC investors said that the meager exit environment was the main challenge to returns over the next year.
Scala Biodesign says the firm enables companies to develop new medicines, green production processes, and foods radically faster and cheaper.